U.S. Markets open in 5 hrs 41 mins

CytomX Therapeutics: 2Q Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ CytomX Therapeutics Inc. (CTMX) on Wednesday reported a loss of $29 million in its second quarter.

The South San Francisco, California-based company said it had a loss of 64 cents per share.

The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 55 cents per share.

The biopharmaceutical company posted revenue of $9 million in the period, which also fell short of Street forecasts. Five analysts surveyed by Zacks expected $15.1 million.

CytomX Therapeutics shares have dropped 28% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $10.92, a decrease of 56% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTMX at https://www.zacks.com/ap/CTMX